The serum concentration of Loteprednol can be decreased when it is combined with Carbamazepine. The metabolism of 4-(2-Aminoethyl)Benzenesulfonyl Fluoride can be increased when combined with Carbamazepine. The metabolism of Zofenopril can be increased when combined with Carbamazepine. The serum concentration of Vortioxetine can be decreased when it is combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Propoxycaine. The metabolism of Glucosamine can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Clidinium. The metabolism of Prazepam can be increased when combined with Carbamazepine. Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine. The serum concentration of Carbamazepine can be decreased when it is combined with Dabrafenib. The metabolism of Candesartan cilexetil can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Chlorprothixene. The metabolism of Prasugrel can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Loprazolam. The metabolism of Amoxapine can be increased when combined with Carbamazepine. The metabolism of Vindesine can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ethyl carbamate. The serum concentration of the active metabolites of Clarithromycin can be increased when Clarithromycin is used in combination with Carbamazepine. The metabolism of Argatroban can be increased when combined with Carbamazepine. The serum concentration of Topiramate can be decreased when it is combined with Carbamazepine. The metabolism of Alpha-1-proteinase inhibitor can be increased when combined with Carbamazepine. The metabolism of Dihydroergotamine can be increased when combined with Carbamazepine. The serum concentration of Macitentan can be decreased when it is combined with Carbamazepine. The metabolism of Parecoxib can be increased when combined with Carbamazepine. Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine. The metabolism of Donepezil can be increased when combined with Carbamazepine. The metabolism of Etizolam can be increased when combined with Carbamazepine. The serum concentration of Oleoyl-estrone can be decreased when it is combined with Carbamazepine. The serum concentration of Carbamazepine can be increased when it is combined with Diltiazem. The metabolism of Synthetic Conjugated Estrogens, B can be increased when combined with Carbamazepine. The metabolism of Torasemide can be increased when combined with Carbamazepine. The metabolism of Ethosuximide can be increased when combined with Carbamazepine. The metabolism of Nilvadipine can be increased when combined with Carbamazepine. The metabolism of Icotinib can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Osanetant. The metabolism of Cholecalciferol can be increased when combined with Carbamazepine. The metabolism of Antithrombin III human can be increased when combined with Carbamazepine. Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. The metabolism of Valdecoxib can be increased when combined with Carbamazepine. The metabolism of Dosulepin can be increased when combined with Carbamazepine. The metabolism of Ketoprofen can be increased when combined with Carbamazepine. The metabolism of Tetracycline can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Hydracarbazine. The metabolism of Ubenimex can be increased when combined with Carbamazepine. Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine. The metabolism of Naproxen can be increased when combined with Carbamazepine. The metabolism of Meprobamate can be increased when combined with Carbamazepine. The serum concentration of Flurandrenolide can be decreased when it is combined with Carbamazepine. The metabolism of Beraprost can be increased when combined with Carbamazepine. The metabolism of Olopatadine can be increased when combined with Carbamazepine. The metabolism of Quinacrine can be increased when combined with Carbamazepine. The metabolism of Carbamazepine can be decreased when combined with Etoperidone. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Oxprenolol. The metabolism of Estrone can be increased when combined with Carbamazepine. Carbamazepine may increase the atrioventricular blocking (AV block) activities of Lacosamide. The therapeutic efficacy of Methallenestril can be decreased when used in combination with Carbamazepine. The metabolism of Sulfadiazine can be increased when combined with Carbamazepine. The serum concentration of Betamethasone can be decreased when it is combined with Carbamazepine. The metabolism of Ketamine can be increased when combined with Carbamazepine. The metabolism of Sulfamethoxazole can be increased when combined with Carbamazepine. The metabolism of Sertindole can be increased when combined with Carbamazepine. The metabolism of Velpatasvir can be increased when combined with Carbamazepine. The metabolism of Baricitinib can be increased when combined with Carbamazepine. The serum concentration of Carbamazepine can be increased when it is combined with Cimetidine. The serum concentration of Nifedipine can be decreased when it is combined with Carbamazepine. The metabolism of Eplerenone can be increased when combined with Carbamazepine. The serum concentration of Imatinib can be decreased when it is combined with Carbamazepine. The metabolism of Lenvatinib can be increased when combined with Carbamazepine. The serum concentration of Carbamazepine can be increased when it is combined with Dorzolamide. The serum concentration of Fluindione can be decreased when it is combined with Carbamazepine. The metabolism of Teniposide can be increased when combined with Carbamazepine. The metabolism of Ergonovine can be increased when combined with Carbamazepine. The metabolism of Lumiracoxib can be increased when combined with Carbamazepine. The metabolism of Nicotine can be increased when combined with Carbamazepine. The metabolism of Dapsone can be increased when combined with Carbamazepine. The serum concentration of the active metabolites of Carbamazepine can be increased when Carbamazepine is used in combination with Loxapine. Carbamazepine may increase the sedative activities of Metyrosine. The serum concentration of Tixocortol can be decreased when it is combined with Carbamazepine. The metabolism of Temazepam can be increased when combined with Carbamazepine. The serum concentration of Dasatinib can be decreased when it is combined with Carbamazepine. The metabolism of Sitagliptin can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Carbamazepine. Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Carbamazepine. The metabolism of Acetylsalicylic acid can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Carbamazepine. The metabolism of Metronidazole can be increased when combined with Carbamazepine. The metabolism of Darifenacin can be increased when combined with Carbamazepine. The metabolism of Clobazam can be increased when combined with Carbamazepine. The metabolism of Pantoprazole can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Dexmedetomidine. The metabolism of Loperamide can be increased when combined with Carbamazepine. The metabolism of Sulfamoxole can be increased when combined with Carbamazepine. Carbamazepine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Halazepam. The serum concentration of Everolimus can be increased when it is combined with Carbamazepine. The serum concentration of the active metabolites of Isavuconazonium can be reduced when Isavuconazonium is used in combination with Carbamazepine resulting in a loss in efficacy. The serum concentration of the active metabolites of Oxcarbazepine can be reduced when Oxcarbazepine is used in combination with Carbamazepine resulting in a loss in efficacy. The metabolism of Losartan can be increased when combined with Carbamazepine. The metabolism of Vinorelbine can be increased when combined with Carbamazepine. The serum concentration of Carbamazepine can be increased when it is combined with Telaprevir. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Ziconotide. The metabolism of Perphenazine can be increased when combined with Carbamazepine. The metabolism of Vinblastine can be increased when combined with Carbamazepine. The serum concentration of Brentuximab vedotin can be decreased when it is combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Metaxalone. The metabolism of Phenoxybenzamine can be increased when combined with Carbamazepine. The metabolism of Oxaprozin can be increased when combined with Carbamazepine. The metabolism of Reboxetine can be increased when combined with Carbamazepine. The metabolism of Metoprolol can be increased when combined with Carbamazepine. The serum concentration of Fluocortolone can be decreased when it is combined with Carbamazepine. The metabolism of Alclometasone can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Glutethimide. The metabolism of Timolol can be increased when combined with Carbamazepine. The metabolism of Almotriptan can be increased when combined with Carbamazepine. The serum concentration of Nilotinib can be decreased when it is combined with Carbamazepine. The metabolism of Bisoprolol can be increased when combined with Carbamazepine. The metabolism of Ivermectin can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Procarbazine. The therapeutic efficacy of Synthetic Conjugated Estrogens, A can be decreased when used in combination with Carbamazepine. The serum concentration of Tolvaptan can be decreased when it is combined with Carbamazepine. The metabolism of Artemether can be increased when combined with Carbamazepine. The metabolism of Methoxyflurane can be increased when combined with Carbamazepine. The metabolism of Cabazitaxel can be increased when combined with Carbamazepine. The metabolism of Cholesterol can be increased when combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Lithium. The serum concentration of Sorafenib can be decreased when it is combined with Carbamazepine. The risk or severity of adverse effects can be increased when Carbamazepine is combined with Lofentanil. The serum concentration of Ibrutinib can be decreased when it is combined with Carbamazepine. The metabolism of Alosetron can be increased when combined with Carbamazepine. The serum concentration of Aminophylline can be decreased when it is combined with Carbamazepine.